By Toko Sekiguchi ( June 27, 2025, 07:03 GMT | Insight) -- A CRISPR patent held by the Regents of the University of California, the University of Vienna and Emmanuelle Charpentier was affirmed by Japan’s Intellectual Property High Court, which dismissed an appeal by South Korean biotech company ToolGen to invalidate it, according to the court’s June 26 opinion obtained by MLex.A CRISPR patent held by the Regents of the University of California, the University of Vienna and Emmanuelle Charpentier was affirmed by Japan’s Intellectual Property High Court yesterday, which dismissed an appeal by South Korean biotech company ToolGen to invalidate it....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.